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INTRODUCTION
Abortion is premature birth of pregnancy before the
fetus is developed enough to be able to live outside
the womb, before 20 weeks gestation, or fetal birth
weight less than 500 gr. Abortion remains a major
problem in obstetric care, because it is one of the
highest cause related to mother and fetus mortality.1-4
The incidence varies from 2% to 22%. The inci-
dence of abortion in general, for 5 - 20% of all preg-
nancy.1 In Hasan Sadikin Hospital, the prevalence of
abortion was recorded at 6.5 to 15%, with the morta-
lity rate is 1 - 2%.
Recurrent miscarriage is a miscarriage incidence at
least twice or more in a row at the age of less than
20 weeks gestation or fetal weight of less than 500
grams.3,5
The cause of abortion can not be determined with
certainty, such as genetic factors, immunological, hor-
monal, anatomical, chronic disease, and lifestyles. The
most common cause of miscarriage is chromosomal
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Objective: To know the change of fibrinogen level in pregnan-
cy with history of abortion and normal pregnancy on 6 - 8 weeks
pregnancy and 10 - 12 weeks pregnancy.
Method: This is a comparative study analytic comparative with
cross sectional method on both groups, pregnancy with history of
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showed that the fibrinogen level in the group with history of abor-
tion increased 9.6% and in the group of normal pregnancy increased
11.4%. The raise on both group was not significant stastistically (p
= 0.810). The raise fibrinogen level on normal pregnancy was sig-
nificant (p < 0.001), while on pregnancy with history of abortion is
not significant (p = 0.255). All patterns of raise and fall on fibrino-
gen level on both groups were not stastistically significant (p >
0.005).
Conclusion: Fibrinogen level on 10 - 12 weeks pregnancy was
not lower than on 6 - 8 weeks pregnancy in pregnancy with history
of abortion. There was no significant raise changes in fibrinogen le-
vel on both groups.
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Abstrak
Tujuan: Mengetahui perubahan kadar fibrinogen pada peme-
riksaan usia kehamilan 6 - 8 minggu dan usia kehamilan 10 - 12
minggu pada kehamilan dengan riwayat abortus dan kehamilan
normal.
Metode: Penelitian ini merupakan penelitian studi perbanding-
an atau perbandingan analisis dengan metode potong silang pada
kedua kelompok kehamilan dengan riwayat abortus dan kehamilan
normal. Penelitian ini mengamati perubahan kadar fibrinogen pa-
da usia 6 - 8 minggu dan kemudian diperiksa kembali pada usia ke-
hamilan 10 - 12 minggu, pada kelompok hamil dengan riwayat
abortus dan kelompok hamil normal.
Hasil: Perbandingan rata-rata kadar fibrinogen antara peme-
riksaan pada 6 - 8 minggu dan pemeriksaan pada 10 - 12 minggu
menunjukkan bahwa pada kelompok kehamilan dengan riwayat
abortus meningkat sebesar 9,6%, sedangkan pada kelompok hamil
normal meningkat 11,4%. Perbandingan peningkatan kadar fibri-
nogen pada kedua kelompok secara statistik tidak bermakna (p =
0,810). Terjadi peningkatan kadar fibrinogen secara signifikan pa-
da kelompok hamil normal (p < 0,001), sedangkan pada kelompok
dengan riwayat abortus peningkatannya tidak bermakna (p =
0,255). Selain itu, tidak ada perbedaan yang bermakna antara ke-
hamilan normal dan riwayat abortus dengan kenaikan atau penu-
runan kadar fibrinogen (p > 0,005).
Kesimpulan: Kadar fibrinogen pada usia 10 - 12 minggu tidak
lebih rendah dibandingkan dengan usia 6 - 8 minggu. Selain itu, ti-
dak ada perbedaan yang bermakna pada persentase peningkatan
kadar fibrinogen pada kelompok hamil normal dan kelompok de-
ngan riwayat abortus.
[Maj Obstet Ginekol Indones 2011; 35-2: 53-6]
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abnormality that occurs in 50% - 80% cases.3 This
genetic disorder has no further intervention to do.
Of the many causes of abortion, hemostatic disor-
ders recently started to get noticed. This is a good
opportunity for us to know better and understand the
causes of abortion. The role of investigation in an ef-
fort to find out the causes of abortion is important
because it can help determine the cause and perhaps
predict the occurrence of obstetric complications that
may be encountered.
Fibrinogen, a major blood glycoprotein, a dimer of
three polypeptide chains, Aα, Bβ, and γ. Fibrinogen
is synthesized in hepatic parenchymal cells and has a
half-life of 3 to 4.5 days. Fibrinogen is the primary
molecule linking the activated platelets together with
the glycoprotein IIb/IIIa.3,6,7
The success of implantation in pregnancy requires
good balance between coagulation, fibrinolysis, and
vascular remodeling. Thrombosis in decidual blood ve-
ssels is one of the causes of abortion, which is the ex-
cessive thrombosis in blood vessels of the placenta, pla-
cental infarction, and insufficiency uteroplasental.8,9
The correlation between abnormalities in blood
clotting process in the case of abortion in Indonesia
today is not widely studied, because the authors were
interested in conducting research to determine the cor-




The amount subjects in this study were  to 32 people
consisting of 16 pregnant patients with a history of
abortion and 16 normal pregnant patients. All patients
underwent blood tests to check levels of fibrinogen
in the blood. In each group, the fibrinogen level was
examined twice. The first examination conducted at
6 - 8 weeks of gestation, while the second inspection
carried out at 10 - 12 weeks of gestation. All patients
are pregnant woman firstly 6 - 8 weeks of gestational
age, based on last menstrual periode, and confirm nor-
mally by ultrasound examination. For pregnancy with
history of abortion, first abortion must not be a mole
or blighted ova. All patient have no haemostatic dis-
orders, and not in infection condition.
Statistical Analysis
Analysis of the data used in this study were the t test
for unpaired data. If data are not normally distributed,
Mann-Whitney test was used, whereas to compare the
characteristics of data (data categories) used x2 (chi
squared). Significance test results are determined
based on the value of p < 0.05.
RESULT
The average age of subjects was 26.2 years in the
group of pregnancies with a history of abortion, while
in the normal pregnant group was 26.6 years.







Age (year) x (SD) 26.2 (2.9) 26.6 (4.8)
Range 21 - 30 20 - 35
Parity
0 16 7
≥ 1  0 9
From Table 2, fibrinogen level examination con-
ducted at 6 - 8 weeks of gestation as a measurement
baseline and at 10 - 12 weeks of gestation as a second
monitor. Preview inspection to I and II between the
two groups of research subjects is not significant.
Table 2. Comparison of Fibrinogen Level
Examination
Fibrinogen (mg/dl) Group





6 - 8 weeks 0.418 0.679
x (SD) 451.9 (129.7) 468 (83.8)
Range 256.2 - 788.7 284.2 - 571.1
10 - 12 weeks 0.776 0.444
x (SD) 484.5 (146.4) 516.2 (72.6)
Range 200.1 - 717.4 344.1 - 602.1
Percentage of raise 9.6 11.4 0.243 0.810
p 0.255 < 0.001
Table 3 shows that the average levels of fibrinogen
in normal pregnant group, either or the first examina-
tion and second examination tended to be higher com-
pared with pregnant groups with a history of abortion,
but it did not indicate any statistically significant dif-
ference (p > 0.05).
Furthermore, comparison of the average fibrinogen
level between the first examination and second ex-
amination showed that the group of pregnancies with
a history of miscarriage increased by 9.6%, while in
the normal pregnant group increased by 11.4%. Com-
parison of elevated levels of fibrinogen in both groups
was not statistically significant (p = 0.810).
The comparison between the elevation level aver-
age of fibrinogen levels in normal pregnant group was
statistically significant (p <0.001), whereas in the
group with a history of abortion did not increase sig-
nificantly (p = 0.255).









Raise 13 (46.4%) 15 (53.6%)
Fall 3 (75%) 1 (25%)
1.143 > 0.05
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From Table 3, it appears that there was no signifi-
cant difference between normal pregnancy and abor-
tion history with the increase or decrease in fibrino-
gen levels (p > 0.005). There are 3 cases decreased
fibrinogen levels in cases with a history of abortion,
but all remained at normal levels fibrinogen. Similar-
ly, in the case of normal pregnancy, there was 1 case
of decreased levels of fibrinogen with the limit levels
are still normal.
DISCUSSION
This study shows that levels of fibrinogen in preg-
nancy is increasing according to gestational age. This
is consistent with studies that have already existed,
stating that in pregnancy, there are some changes on
the components associated with blood clotting fac-
tor.10
Pregnancy-related changes in hemostasis, including
the majority of the increase in clotting factors, the de-
cline in the number of natural anticoagulants, and re-
duction in fibrinolytic activity. These changes produ-
ce a state body at the level of hypercoagulability.10,11
Fibrinogen increased according to gestational age,
but from these studies, no content limits obtained im-
provement.12-15 But Patrick et al. revealed that eleva-
ted levels of fibrinogen up to two times above normal
may occur in pregnancy.10
An increase in fibrinogen is in line with its role as
a hemostatic agent, which achieved a balance of adhe-
sion utero plasental fibrinoid layer on the fabric of
the mother and fetus.9 The role of fibrinogen is in the
stabilization phase fibrinoid layer is very important in
the pressed layers of trophoblast into the decidua.
Etiology of an abortion are extremely diverse and
many possibilities, so that a deeper observation is
needed to determine the etiology, both abortion his-
tory, as well as recurrent miscarriage.
Haematological abnormalities either acquired or in-
herited is one of the causes of which are sufficient
counts.3,16,17 These blood disorders such as sickle cell
anemia, disfibrinogenemia, hipofibrinogenemia conge-
nital, afibrinogenemia, Wilson’s disease, and hiperho-
mosisteinemia may be a cause of abortion.8
Various studies, found no relationship between in-
cidence of abortion, as well as recurrent miscarriage
with low levels of fibrinogen. Plasma fibrinogen is a
predictor of a very strong and consistent in a moment
of clinical ischemia, which is mainly caused by arte-
rial thrombosis.18 Adhesion of platelets is the begin-
ning of the cascade, which converts soluble fibrinogen
into insoluble and cause blood clotting, platelet adhe-
sion and aggregation is very important to prevent ble-
eding that causes death. Adhesion of platelets that
cause atherosclerosis accelerate the formation of pla-
que, so that the occlusive against the distal tissue.18-20
Beside, there are differences in coagulation para-
meters between IUFD with normal pregnancies, na-
mely platelets, PT, aPTT, TT, fibrinogen, and anti-
trombin III.21,22
Kitchens Bolton and each also concluded that wo-
men with afibrinogenemia and hipofibrinogenemia
have a higher risk of experiencing abortion.23,24
In this study, no single case of patients experienced
hipofibrinogenemia, and in its development there was
no cases of abortion. There was a significant impro-
vement in the normal pregnant group, while in the
group with a history of abortion was not found sig-
nificant improvement.
This study tried to reveal the possible etiology
from the standpoint of blood clotting factor disorders,
at the time of the incident just after 1 time abortion.
Recurrent miscarriage requires at least 2 times the
incidence of abortion in a row, this may cause signi-
ficant psychological effect on patient25, and genetic
problem can not be manipulated, therefore, the writer
studied in patients with a history of abortion 1 time
only.
Further research that can support and that are useful
to know the etiology of abortion with respect to distur-
bances in blood clotting system, such as fibrinogen and
platelet function tests is required. Some studies reveal
a link between fibrinogen levels in early pregnancy with
obstetric complications at a later date.
Fibrinogen levels increase with gestational age,
whereas prothrombin time and overall activity of vi-
tamin K dependent coagulation factors decrease be-
fore labor, it describes the physiological response to
prevent bleeding during parturien.13,26,27 From this,
other studies can be linked later known fibrinogen
level during early pregnancy, to be used as a tool in
determining the risk of deadly complications during
childbirth.
Vascular anomalies of the placenta can result in
various pathologies of pregnancy, including first and
second trimester abortion, IUGR, IUFD, preeclamp-
sia, and bleeding post-saline.16 Furthermore, levels of
fibrinogen are associated with a disturbance stability
of the placenta, may also be examined as predictors
of pregnancy complications.
CONCLUSIONS AND SUGGESTION
Fibrinogen level at 10 - 12 weeks of age is not lower
than the age of 6 - 8 weeks. There was no significant
difference in the percentage increase in fibrinogen le-
vels in normal pregnant group and the group with a
history of abortion.
As suggestion, there should be other studies related
to blood clotting factor that may be related to the eti-
ology of abortion, and research to predict the oc-cur-
rence of obstetric complications such as IUFD, IUGR,
preeclampsia, and post partum haemorrhage.
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